Searchable abstracts of presentations at key conferences in endocrinology

ea0019p114 | Cytokines and growth factors | SFEBES2009

Expression and purification of a potential long-acting leptin agonist

Carpenter B , Pradhananga S , Wilkinson I , Justice S , Artymiuk P , Ross R

Background: Leptin is an important regulator of the immune response. Therapeutics that modulate leptin signalling are considered to be a potential targets in a number of immune related conditions. The role of leptin antagonists to suppress the immune system, slowing the progression of autoimmune diseases is a widely discussed idea. However, leptin agonists may also be useful to up-regulate the immune response during malnutrition. The aim of this project was to develop long-las...

ea0019p169 | Endocrine tumours and neoplasia | SFEBES2009

Overexpression of human RAMP3 (receptor activity-modifying protein-3) in E. coli and mammalian cells

Kaabi Y , Wilkinson I , Carpenter B , Richards G , Skerry T , Ross RJ

Introduction: RAMPs (receptor activity-modifying proteins) are single-pass transmembrane accessory proteins required for appropriate signalling of the G-protein coupled receptors; CRLR (Calcitonin receptor like receptor) and CTR (Calcitonin receptor). There are three forms of human RAMPs known as, RAMP1, 2 and 3. RAMP3 heterodimerises with CRLR or CTR to form a high affinity receptor for the peptide hormones adrenomedullin and amylin, respectively. However, the exact mechanism...

ea0004oc13 | Endocrine tumours and neoplasia | SFE2002

Expression of insulin-like growth factor binding protein-3(IGFBP-3) is down regulated in breast cancer compared to normal breast tissue

McCarthy K , Laban C , Bustin S , Ogunkolade B , Carpenter R , Jenkins P

Background: Recent studies have suggested that an increased level of serum IGF-1 and a decreased level of IGFBP-3 may be associated with an increased risk of developing subsequent breast cancer. However, it is uncertain whether these effects are mediated solely by endocrine actions or whether local effects might also be important. We have previously demonstrated IGF-1 mRNA to be universally expressed in normal breast tissue but in only 50% of cancers. The expression of IGFBP-3...